CLOSE X
GO

Motilal Oswal Nifty Midcap 100 ETF

very highequityindex
58.97 0.69(1.18%) NAV as on 23 Apr 2025
6.11 % 1 M
11.47 % 1 Y
22.55 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The Scheme seeks investment return that corresponds (before fees and expenses) to the performance of CNXMidcap Index (Underlying Index), subject to tracking error.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

0.22

As on 31 Mar, 2025
age-icon Age :

14 yrs 2 m

Since 03 02 ,2011
exit_load Exit Load :

0%

aum AUM :

542.67 Crs

lock_in Lock-in :

Nil

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

8.62

Min_Investment Min. Investment :

SIP NA & Lumpsum 10000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Swapnil P Mayekar,Dishant Mehta,Rakesh Shetty

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2025
Others -0.02 %
Equity 100.02 %

TOP HOLDINGS

Max Healthcare Institute Ltd.3.29 %
BSE Ltd.3.00 %
Suzlon Energy Ltd.2.72 %
Persistent Systems Ltd.2.37 %
Coforge Ltd.2.18 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

IT - Software8.47
Pharmaceuticals & Drugs7.00
Bank - Private6.27
Finance - NBFC4.24
Finance - Others4.20
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)24.7831.3431.8251.2655.36
Net Assets(Rs Crores) (as on 31-Mar-2025) 57.06 91.75 152.02 380.74 542.67
Scheme Returns(%)(Absolute)104.8624.290.0560.406.15
B'mark Returns(%)(Absolute)NANANANANA
Category Rank1/855/11186/16024/201104/238

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Motilal Oswal Nifty Midcap 100 ETFVery HighEquity58.970.69(1.18%)NAV As on 23 Apr, 202503-Feb-2011Inception Date542.67AUM In Cr.11.47%1Y22.55%3Y33.95%5Y15.22%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors